B-1: Seeking technologies for rapid extraction and concentration of Hepatitis B Virus DNA

[CC-Conrad Clyburn-MedForeSight]

Overview

When HBV virus DNA is extracted from patients in early stage infection or with low virus load (less than 10e2 copies/ml), there is no appropriate DNA concentration procedure and the HBV DNA can usually not be detected by quantitive PCR methods. This client seeks to develop a rapid and effective method to purify and concentrate the DNA of the HBV virus from a patients serum. They are looking for technologies that can deliver ten times DNA concentration of the HBV virus, from serum, i.e., the detection sensibility of the diagnostic kit should be ≥10e2/ml.

[Gary F. Buck]

Good Morning CC;
Greetings and Best Wishes for a Happy Holiday Season. I am intrigued by the NextTechs announcement and would like to push a brief executive summary to them for their consideration as we seek growth capital funding, either through straight equity investment, or via a strategic corporate partner (preferred) in the vision care industry.
Please advise fo most direct way to do this.
Regards,
Gary

[Matt Granger]

I would recommend talking to Switch Gear and see if they can assist.

http://www.switchgeargenomics.com/

Matt Granger
Akimeka, LLC
[e-mail]
808-442-7130